ɫɫÀ²

News

What if nanotech could save lives?

Xfold Imaging’s innovative solutions enable the study of cellular structures and bio-molecules at a nano-scale resolution which has, up until now, not been possible. Looking this deep will give earlier diagnostics to stop disease outbreaks in their tracks, allow pharmaceutical companies to design better drugs.
photo: Aleksi Neuvonen
Photo: Aleksi Neuvonen

The company has created what looks like a straightforward piece of glass, but what is actually a powerful signal enhancer that can be incorporated into existing microscopes, thus giving way more power and possibilities than vastly more expensive microscopes.

Xfold Imaging is a spin-out from Aalto University and the University of Helsinki and the idea initially came from co-founder, Naga Subramaniyam, who’s background is in nanoscience and with experience in working with nanofabrication and spectroscopy. As part of his research, he had a co-operation with Biomedicum in Helsinki, so it was only natural to focus on med-tech oriented research. 

The glass has been designed as such that it can be utilised on most laboratory microscopes, Xfold's CEO Timo Jantti, says ‘Our technology, which we call Surface-Enhanced Biomedical Imaging, can create a one hundredfold biomedical image, and without any requirements to upgrade or modernise an existing fleet of equipment.

Previously, to get any meaningful results from cell observation, a process of bleaching has been needed to amplify the cell signal. The main problem is that cell bleaching cuts the life of the cell, so observation time is minimal; getting enough observation time is crucial to determining cell activity, or to chemical reaction testing.

Jantti proudly says, ‘When demonstrating our technology to scientists, the live-cell imaging is something that they love; While you can also see the cell better, you can also see the cell life one hundred times longer as less energy is used due to the cell not being bleached’. This means that diagnostics time could be cut in half, which would potentially save lives at the beginning of an epidemic (at the extreme end of the scale).

With full commercialisation in action, Xfold’s solution will enable researchers to have unprecedented access to identifying totally new things, therefore offering opportunities for breakthroughs in research as well. 

While the biomedical sector is the main focus at this stage, Xfold has also been asked to provide solutions for satellites and mobile phone batteries. However, Jantti and Xfold are looking even further ahead, ‘We are constantly developing even more powerful live-cell possibilities so if the imaging level would be raised from 100% to 400%, AI could maybe start processing the information that the human eye can’t see, and who knows what will be discovered?!’.

Xfold Imaging, founded in 2018

Founders:

Timo Jäntti – CEO
Nagarajan Subramaniyam- CTO
Markku Sopanen
Antti Isomäki
Saija Silvola
Janne Mäkelä

Major company milestones:

2017-2018 - TUTL funded project jointly with Aalto University and University of Helsinki

2018 Q3 - Xfold Imaging Oy was established

2019 Q2 - Operation Started & First finance round with VC / Butterfly Venture

2019 Q3 - Pilots running in leading Universities in 3 continents; including Okinawa and Stanford among others

2019 Q3 - The first sale has happened. We are in BUSINESS!

  • Updated:
  • Published:
Share
URL copied!

Read more news

Two people wearing headphones sit at a desk with a large screen in a dimly lit office.
Cooperation, University Published:

Unite! Networking Hub Launches: Exchange best practices and learn from peers across Europe

The Unite! Networking Hub is an online space for Unite! faculty and staff to meet to connect and engage with colleagues in the same field of expertise, share and discover best practices, and support one another in addressing work-related challenges.
An illustrative figure comparing disease-induced immunity (left) and randomly distributed immunity (right) in the same network. Illustration: Jari Saramäki's research group, Aalto UIniversity.
Research & Art Published:

Herd immunity may not work how we think

A new study from researchers at Aalto University suggests that our picture of herd immunity may be incomplete — and that understanding how people are connected could be just as important as knowing how many are immune.
AI applications
Research & Art Published:

Aalto computer scientists in ICML 2025

Department of Computer Science papers accepted to International Conference on Machine Learning (ICML)
Close-up of a glowing dual processor on a dark motherboard with futuristic light effects and detailed circuitry.
Press releases, Research & Art Published:

New quantum record: Transmon qubit coherence reaches millisecond threshold

The result foreshadows a leap in computational capabilities, with researchers now inviting experts around the globe to reproduce the groundbreaking measurement.